Clinical Trial Update: The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating three intra-articular doses of Triamcinolone acetonide (5 mg, 10 mg, 40 mg) for knee osteoarthritis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Kenalog (Triamcinolone acetonide) (Triamcinolone acetonide)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Primary Gonarthrosis | Phase 4 | Status: RECRUITING